![Mai-Britt Zocca](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mai-Britt Zocca
Directeur Général chez
IO Biotech ApS
Fortune : 466 $ au 30/06/2026
Profil
Dr. Mai-Britt Zocca is a Chief Executive Officer at Elevara Medicines Ltd., a President & Chief Executive Officer at IO Biotech ApS, a Program Director at Entrepreneurial Learning Lab and a Senior Manager-Program at Cobis A/S.
She is on the Board of Directors at Valo Therapeutics Oy.
Dr. Zocca was previously employed as a President, Chief Executive Officer & Director by IO Biotech, Inc., a Chief Executive Officer by LevOss ApS, a Chief Executive Officer & Director by OncoNOx ApS, a Chief Executive Officer by Enochian Biosciences Denmark ApS, a Senior Program Manager by Copenhagen Business Center, a Principal by Copenhagen University Hospital, a Program Director by Symbion A/S, and a Principal by University of Copenhagen.
She also served on the board at Dansk Biotek.
She received her graduate degree from the University of Copenhagen and a doctorate degree from the University of Copenhagen.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
IO BIOTECH, INC. 0,11% | 11/04/2025 | 76 471 ( 0,11% ) | 466 $ | 30/06/2026 |
Postes actifs de Mai-Britt Zocca
| Sociétés | Poste | Début |
|---|---|---|
Cobis A/S
 Cobis A/S Miscellaneous Commercial ServicesCommercial Services Provides business support services | Corporate Officer/Principal | - |
Entrepreneurial Learning Lab | Corporate Officer/Principal | - |
IO Biotech ApS
 IO Biotech ApS BiotechnologyHealth Technology Develops disruptive immune therapies | Directeur Général | 01/01/2015 |
Valo Therapeutics Oy
 Valo Therapeutics Oy Pharmaceuticals: MajorHealth Technology Develops novel immunotherapies for cancer and infectious disease | Directeur/Membre du Conseil | 08/06/2020 |
Anciens postes connus de Mai-Britt Zocca
| Sociétés | Poste | Fin |
|---|---|---|
| IO BIOTECH, INC. | Directeur Général | 31/03/2026 |
OncoNOx ApS
 OncoNOx ApS Pharmaceuticals: MajorHealth Technology Provides drugs for the treatment of autoimmune diseases and cancer | Fondateur | 01/05/2019 |
LevOss ApS
 LevOss ApS BiotechnologyHealth Technology Provides implant device for treatment of musculoskeletal | Directeur Général | 01/01/2017 |
Renovaro Biosciences Denmark ApS
 Renovaro Biosciences Denmark ApS Miscellaneous Commercial ServicesCommercial Services Engages in research and development of medicines | Directeur Général | 01/12/2010 |
Dansk Biotek
 Dansk Biotek Miscellaneous Commercial ServicesCommercial Services Operates as an industry association for biotech companies with promoting the biotechnological research | Directeur/Membre du Conseil | - |
Formation de Mai-Britt Zocca
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
11
Relations au 1er degré
13
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 13 |
|---|---|
Symbion A/S
 Symbion A/S General GovernmentGovernment Provides office communities, meeting rooms, conference facilities, business development, and capital for start-up companies | Government |
University of Copenhagen
 University of Copenhagen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Dansk Biotek
Dansk Biotek Miscellaneous Commercial ServicesCommercial Services Operates as an industry association for biotech companies with promoting the biotechnological research | Commercial Services |
Copenhagen Business Center | |
Copenhagen University Hospital
 Copenhagen University Hospital Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
OncoNOx ApS
OncoNOx ApS Pharmaceuticals: MajorHealth Technology Provides drugs for the treatment of autoimmune diseases and cancer | Health Technology |
Renovaro Biosciences Denmark ApS
Renovaro Biosciences Denmark ApS Miscellaneous Commercial ServicesCommercial Services Engages in research and development of medicines | Commercial Services |
LevOss ApS
LevOss ApS BiotechnologyHealth Technology Provides implant device for treatment of musculoskeletal | Health Technology |
Entrepreneurial Learning Lab | |
IO Biotech ApS
IO Biotech ApS BiotechnologyHealth Technology Develops disruptive immune therapies | Health Technology |
Valo Therapeutics Oy
Valo Therapeutics Oy Pharmaceuticals: MajorHealth Technology Develops novel immunotherapies for cancer and infectious disease | Health Technology |
Cobis A/S
Cobis A/S Miscellaneous Commercial ServicesCommercial Services Provides business support services | Commercial Services |
IO Biotech, Inc.
 IO Biotech, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops novel, immune-modulating cancer therapies | Health Technology |
Choisissez Zonebourse 
